Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Topsun Group is a prominent Chinese pharmaceutical conglomerate headquartered in Xi'an, Shaanxi Province. Established in 1998, the company has evolved into a multi-faceted enterprise encompassing drug research and development, manufacturing, and distribution, with a strong emphasis on both Traditional Chinese Medicine (TCM) and modern chemical pharmaceuticals. Its extensive product portfolio targets major therapeutic areas including cardiovascular diseases, respiratory infections, and gastrointestinal health, featuring over 100 approved medications. The group operates state-of-the-art GMP-certified production facilities and maintains a significant presence in the Chinese domestic healthcare market. Xi'an Topsun Group is recognized for its integration of traditional herbal knowledge with modern pharmaceutical manufacturing standards, serving as a key player in the regional economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Topsun Group.